- December 17, 2025
Three new cases of severe mpox were reported in California. Infectious disease expert Amira Roess clarifies the differences, and similarities, between the types of mpox.
- December 8, 2025
Vaccination and health behavior expert Rupali Limaye offers timely information amidst recent changes to Centers for Disease Control vaccine recommendations for infant immunization schedules.
- November 27, 2025
H5N5 avian influenza remains extremely rare in the United States, with only isolated detections and no evidence of sustained human-to-human spread. Public health authorities continue to monitor the situation closely, especially following the recent fatal case, but current indicators still point to a low overall risk for the general population.
- September 30, 2025
Biosecurity expert Terri Rebmann talks about her new book chapter on the overlooked phase of biological disasters
- September 25, 2025
Epidemiologist Amira Roess explains the science behind herd immunity and the important role vaccines play in fighting infectious diseases
- September 10, 2025
Dietary behavior expert at George Mason University answers questions about the pros and cons of whole milk in light of new U.S. dietary guidelines.
- September 2, 2025
Healthy aging scholar and gerontologist Li-Mei Chen warns that older adults aged 60 years and older face disproportionate risks of dehydration, heat stroke, exhaustion, and other heat-related illnesses.
- June 18, 2025
Teen dating violence expert Daphne King breaks down the dangers of unequal power dynamics in relationships as the Combs trial draws to a close.
- April 16, 2025
Amira Roess shares updated measles information and the implications of the growing number of outbreaks in the U.S. and Mexico.
- April 11, 2025
After nearly three years of backorders and pharmacy scrambles, the high-demand weight-loss drugs Ozempic, Wegovy, and Mounjaro are finally back in full supply. The FDA recently declared an end to the nationwide shortage of their active ingredients, semaglutide and tirzepatide. Martin Binks, chair of the Department of Nutrition and Food Studies at George Mason University and a researcher and clinician with expertise in obesity, explains what this moment means for patients, providers, and public health.